A citation-based method for searching scientific literature

Romain Banchereau, Avantika S Chitre, Alexis Scherl, Thomas D Wu, Namrata S Patil, Patricia de Almeida, Edward E Kadel Iii, Shravan Madireddi, Amelia Au-Yeung, Chikara Takahashi, Ying-Jiun Chen, Zora Modrusan, Jacqueline McBride, Rhea Nersesian, Ehab A El-Gabry, Mark D Robida, Jeffrey C Hung, Marcin Kowanetz, Wei Zou, Mark McCleland, Patrick Caplazi, Shadi Toghi Eshgi, Hartmut Koeppen, Priti S Hegde, Ira Mellman, W Rodney Mathews, Thomas Powles, Sanjeev Mariathasan, Jane Grogan, William E O'Gorman. J Immunother Cancer 2021
Times Cited: 5







List of co-cited articles
15 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors.
Thomas Duhen, Rebekka Duhen, Ryan Montler, Jake Moses, Tarsem Moudgil, Noel F de Miranda, Cheri P Goodall, Tiffany C Blair, Bernard A Fox, Jason E McDermott,[...]. Nat Commun 2018
253
60

CD8+CD103+ tumor-infiltrating lymphocytes are tumor-specific tissue-resident memory T cells and a prognostic factor for survival in lung cancer patients.
Fayçal Djenidi, Julien Adam, Aïcha Goubar, Aurélie Durgeau, Guillaume Meurice, Vincent de Montpréville, Pierre Validire, Benjamin Besse, Fathia Mami-Chouaib. J Immunol 2015
308
60

Tissue-resident memory features are linked to the magnitude of cytotoxic T cell responses in human lung cancer.
Anusha-Preethi Ganesan, James Clarke, Oliver Wood, Eva M Garrido-Martin, Serena J Chee, Toby Mellows, Daniela Samaniego-Castruita, Divya Singh, Grégory Seumois, Aiman Alzetani,[...]. Nat Immunol 2017
231
60

TOX is a critical regulator of tumour-specific T cell differentiation.
Andrew C Scott, Friederike Dündar, Paul Zumbo, Smita S Chandran, Christopher A Klebanoff, Mojdeh Shakiba, Prerak Trivedi, Laura Menocal, Heather Appleby, Steven Camara,[...]. Nature 2019
279
40

TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion.
Omar Khan, Josephine R Giles, Sierra McDonald, Sasikanth Manne, Shin Foong Ngiow, Kunal P Patel, Michael T Werner, Alexander C Huang, Katherine A Alexander, Jennifer E Wu,[...]. Nature 2019
351
40

HPV vaccines - A review of the first decade.
Diane M Harper, Leslie R DeMars. Gynecol Oncol 2017
166
40

Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer.
Naiyer A Rizvi, Matthew D Hellmann, Alexandra Snyder, Pia Kvistborg, Vladimir Makarov, Jonathan J Havel, William Lee, Jianda Yuan, Phillip Wong, Teresa S Ho,[...]. Science 2015
40


Heterogenous Populations of Tissue-Resident CD8+ T Cells Are Generated in Response to Infection and Malignancy.
J Justin Milner, Clara Toma, Zhaoren He, Nadia S Kurd, Quynh P Nguyen, Bryan McDonald, Lauren Quezada, Christella E Widjaja, Deborah A Witherden, John T Crowl,[...]. Immunity 2020
51
40

Fatty Acid Oxidation Controls CD8+ Tissue-Resident Memory T-cell Survival in Gastric Adenocarcinoma.
Run Lin, Hui Zhang, Yujie Yuan, Qiong He, Jianwen Zhou, Shuhua Li, Yu Sun, Daniel Y Li, Hai-Bo Qiu, Wei Wang,[...]. Cancer Immunol Res 2020
28
40

CD103+CD8+ TRM Cells Accumulate in Tumors of Anti-PD-1-Responder Lung Cancer Patients and Are Tumor-Reactive Lymphocytes Enriched with Tc17.
Stéphanie Corgnac, Ines Malenica, Laura Mezquita, Edouard Auclin, Elodie Voilin, Jamila Kacher, Heloise Halse, Laetitia Grynszpan, Nicolas Signolle, Thibault Dayris,[...]. Cell Rep Med 2020
13
40

Interlesional diversity of T cell receptors in melanoma with immune checkpoints enriched in tissue-resident memory T cells.
Chandra Sekhar Boddupalli, Noffar Bar, Krishna Kadaveru, Michael Krauthammer, Natopol Pornputtapong, Zifeng Mai, Stephan Ariyan, Deepak Narayan, Harriet Kluger, Yanhong Deng,[...]. JCI Insight 2016
83
40

Human Tissue-Resident Memory T Cells Are Defined by Core Transcriptional and Functional Signatures in Lymphoid and Mucosal Sites.
Brahma V Kumar, Wenji Ma, Michelle Miron, Tomer Granot, Rebecca S Guyer, Dustin J Carpenter, Takashi Senda, Xiaoyun Sun, Siu-Hong Ho, Harvey Lerner,[...]. Cell Rep 2017
389
40

Memory T cells in nonlymphoid tissue that provide enhanced local immunity during infection with herpes simplex virus.
Thomas Gebhardt, Linda M Wakim, Liv Eidsmo, Patrick C Reading, William R Heath, Francis R Carbone. Nat Immunol 2009
720
40

Two subsets of memory T lymphocytes with distinct homing potentials and effector functions.
F Sallusto, D Lenig, R Förster, M Lipp, A Lanzavecchia. Nature 1999
40

Consensus guidelines for the definition, detection and interpretation of immunogenic cell death.
Lorenzo Galluzzi, Ilio Vitale, Sarah Warren, Sandy Adjemian, Patrizia Agostinis, Aitziber Buqué Martinez, Timothy A Chan, George Coukos, Sandra Demaria, Eric Deutsch,[...]. J Immunother Cancer 2020
171
20

T Cell Epitope Predictions.
Bjoern Peters, Morten Nielsen, Alessandro Sette. Annu Rev Immunol 2020
42
20

Personal neoantigen vaccines induce persistent memory T cell responses and epitope spreading in patients with melanoma.
Zhuting Hu, Donna E Leet, Rosa L Allesøe, Giacomo Oliveira, Shuqiang Li, Adrienne M Luoma, Jinyan Liu, Juliet Forman, Teddy Huang, J Bryan Iorgulescu,[...]. Nat Med 2021
38
20

Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion.
Robert D Schreiber, Lloyd J Old, Mark J Smyth. Science 2011
20

Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma.
Robert J Motzer, Bernard Escudier, David F McDermott, Saby George, Hans J Hammers, Sandhya Srinivas, Scott S Tykodi, Jeffrey A Sosman, Giuseppe Procopio, Elizabeth R Plimack,[...]. N Engl J Med 2015
20

Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma.
Willy Hugo, Jesse M Zaretsky, Lu Sun, Chunying Song, Blanca Homet Moreno, Siwen Hu-Lieskovan, Beata Berent-Maoz, Jia Pang, Bartosz Chmielowski, Grace Cherry,[...]. Cell 2016
20

Immune checkpoint inhibitors in the treatment of virus-associated cancers.
Peipei Gao, Cordelle Lazare, Canhui Cao, Yifan Meng, Ping Wu, Wenhua Zhi, Shitong Lin, Juncheng Wei, Xiaoyuan Huang, Ling Xi,[...]. J Hematol Oncol 2019
20
20

Cellular cytotoxicity is a form of immunogenic cell death.
Luna Minute, Alvaro Teijeira, Alfonso R Sanchez-Paulete, Maria C Ochoa, Maite Alvarez, Itziar Otano, Iñaki Etxeberrria, Elixabet Bolaños, Arantza Azpilikueta, Saray Garasa,[...]. J Immunother Cancer 2020
19
20


Comprehensive Meta-analysis of Key Immune-Related Adverse Events from CTLA-4 and PD-1/PD-L1 Inhibitors in Cancer Patients.
Guillermo De Velasco, Youjin Je, Dominick Bossé, Mark M Awad, Patrick A Ott, Raphael B Moreira, Fabio Schutz, Joaquim Bellmunt, Guru P Sonpavde, F Stephen Hodi,[...]. Cancer Immunol Res 2017
217
20

Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden.
Zachary R Chalmers, Caitlin F Connelly, David Fabrizio, Laurie Gay, Siraj M Ali, Riley Ennis, Alexa Schrock, Brittany Campbell, Adam Shlien, Juliann Chmielecki,[...]. Genome Med 2017
20

Immune surveillance of tumors.
Jeremy B Swann, Mark J Smyth. J Clin Invest 2007
824
20

Mismatch Repair Protein Deficiency Is a Risk Factor for Aberrant Expression of HLA Class I Molecules: A Putative "Adaptive Immune Escape" Phenomenon.
Terufumi Kubo, Yoshihiko Hirohashi, Kazuhiko Matsuo, Tomoko Sonoda, Hiroki Sakamoto, Kiyoshi Furumura, Tomohide Tsukahara, Takayuki Kanaseki, Munehide Nakatsugawa, Hiroshi Hirano,[...]. Anticancer Res 2017
7
20

A vaccine targeting mutant IDH1 induces antitumour immunity.
Theresa Schumacher, Lukas Bunse, Stefan Pusch, Felix Sahm, Benedikt Wiestler, Jasmin Quandt, Oliver Menn, Matthias Osswald, Iris Oezen, Martina Ott,[...]. Nature 2014
395
20

Lessons learned from cancer vaccine trials and target antigen choice.
Lisa H Butterfield. Cancer Immunol Immunother 2016
17
20

Prognostic value of HLA class I expression in patients with colorectal cancer.
Yuji Iwayama, Tetsuhiro Tsuruma, Toru Mizuguchi, Tomohisa Furuhata, Nobuhiko Toyota, Masayuki Matsumura, Toshihiko Torigoe, Noriyuki Sato, Koichi Hirata. World J Surg Oncol 2015
15
20

The immune response to secondary necrotic cells.
Monika Sachet, Ying Yu Liang, Rudolf Oehler. Apoptosis 2017
104
20

Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer.
Seung Tae Kim, Razvan Cristescu, Adam J Bass, Kyoung-Mee Kim, Justin I Odegaard, Kyung Kim, Xiao Qiao Liu, Xinwei Sher, Hun Jung, Mijin Lee,[...]. Nat Med 2018
464
20

The Immunoscore in Localized Urothelial Carcinoma Treated with Neoadjuvant Chemotherapy: Clinical Significance for Pathologic Responses and Overall Survival.
Elise F Nassif, Bernhard Mlecnik, Constance Thibault, Marie Auvray, Daniela Bruni, Alexandre Colau, Eva Compérat, Gabriela Bindea, Aurélie Catteau, Aurélie Fugon,[...]. Cancers (Basel) 2021
2
50

CCL5-deficiency enhances intratumoral infiltration of CD8+ T cells in colorectal cancer.
Shengbo Zhang, Ming Zhong, Chao Wang, Yanjie Xu, Wei-Qiang Gao, Yan Zhang. Cell Death Dis 2018
22
20

A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma.
P van der Bruggen, C Traversari, P Chomez, C Lurquin, E De Plaen, B Van den Eynde, A Knuth, T Boon. Science 1991
20

Cisplatin-induced immune modulation in ovarian cancer mouse models with distinct inflammation profiles.
Shannon Grabosch, Mirna Bulatovic, Feitianzhi Zeng, Tianzhou Ma, Lixin Zhang, Malcolm Ross, Joan Brozick, YuSi Fang, George Tseng, Eun Kim,[...]. Oncogene 2019
62
20

Prospective multi-institutional evaluation of pathologist assessment of PD-L1 assays for patient selection in triple negative breast cancer.
Emily S Reisenbichler, Gang Han, Andrew Bellizzi, Veerle Bossuyt, Jane Brock, Kimberly Cole, Oluwole Fadare, Omar Hameed, Krisztina Hanley, Beth T Harrison,[...]. Mod Pathol 2020
36
20


Neoantigen identification strategies enable personalized immunotherapy in refractory solid tumors.
Fangjun Chen, Zhengyun Zou, Juan Du, Shu Su, Jie Shao, Fanyan Meng, Ju Yang, Qiuping Xu, Naiqing Ding, Yang Yang,[...]. J Clin Invest 2019
65
20

Less correlation between mismatch repair proteins deficiency and decreased expression of HLA class I molecules in endometrial carcinoma: a different propensity from colorectal cancer.
Tasuku Mariya, Terufumi Kubo, Yoshihiko Hirohashi, Junko Yanagawa, Yuta Tabuchi, Kazuhiko Matsuo, Kiyoshi Furumura, Rena Morita, Munehide Nakatsugawa, Takayuki Kanaseki,[...]. Med Mol Morphol 2021
1
100

Phase III randomized clinical trial comparing tremelimumab with standard-of-care chemotherapy in patients with advanced melanoma.
Antoni Ribas, Richard Kefford, Margaret A Marshall, Cornelis J A Punt, John B Haanen, Maribel Marmol, Claus Garbe, Helen Gogas, Jacob Schachter, Gerald Linette,[...]. J Clin Oncol 2013
522
20

A systematic review of the cost and cost-effectiveness studies of immune checkpoint inhibitors.
Vivek Verma, Tanja Sprave, Waqar Haque, Charles B Simone, Joe Y Chang, James W Welsh, Charles R Thomas. J Immunother Cancer 2018
122
20

Landscape of Tumor Antigens in T Cell Immunotherapy.
Sadia Ilyas, James C Yang. J Immunol 2015
74
20



Prevalence of Lynch syndrome among patients with newly diagnosed endometrial cancers.
Cecilia Egoavil, Cristina Alenda, Adela Castillejo, Artemio Paya, Gloria Peiro, Ana-Beatriz Sánchez-Heras, Maria-Isabel Castillejo, Estefanía Rojas, Víctor-Manuel Barberá, Sonia Cigüenza,[...]. PLoS One 2013
74
20

PD-1 blockade induces responses by inhibiting adaptive immune resistance.
Paul C Tumeh, Christina L Harview, Jennifer H Yearley, I Peter Shintaku, Emma J M Taylor, Lidia Robert, Bartosz Chmielowski, Marko Spasic, Gina Henry, Voicu Ciobanu,[...]. Nature 2014
20

A large fraction of HLA class I ligands are proteasome-generated spliced peptides.
Juliane Liepe, Fabio Marino, John Sidney, Anita Jeko, Daniel E Bunting, Alessandro Sette, Peter M Kloetzel, Michael P H Stumpf, Albert J R Heck, Michele Mishto. Science 2016
211
20

TOX reinforces the phenotype and longevity of exhausted T cells in chronic viral infection.
Francesca Alfei, Kristiyan Kanev, Maike Hofmann, Ming Wu, Hazem E Ghoneim, Patrick Roelli, Daniel T Utzschneider, Madlaina von Hoesslin, Jolie G Cullen, Yiping Fan,[...]. Nature 2019
247
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.